文献速递关节外科

锥形钛多孔等离子喷涂股骨假体至少25年随访结果

Minimum 25-Year Results of a Tapered Titanium Porous Plasma Spray Coated Femoral Component.
PubMed 文献 · J Arthroplasty · 2023-03-15

该研究回顾性分析了本中心使用锥形钛多孔等离子喷涂股骨假体行初次非骨水泥全髋关节置换术的患者,至少随访25年(范围25至37年)。共332例患者(396髋),平均手术年龄48岁。37年时全因股骨柄翻修生存率为94.8%(95%CI:±0.9%),无菌性松动/骨长入失败翻修生存率为98.7%(95%CI:±0.5)。Harris髋关节评分从术前43显著提高至最近随访76。

要点

  • 37年全因股骨柄翻修生存率94.8%,无菌性松动/骨长入失败翻修生存率98.7%。
  • 31例股骨翻修(7.8%),感染9例、骨长入失败3例、无菌性松动5例。
  • Harris髋关节评分从术前43显著提高至最近随访76。

核心结论

  • 锥形钛多孔等离子喷涂股骨假体在长期随访中持续表现出高生存率,全因翻修率及无菌性松动/骨长入失败翻修率均较低。

研究设计与样本

  • 回顾性分析本中心截至1995年使用特定股骨假体行初次非骨水泥全髋关节置换术的患者,该假体自1984年引入后基本未变,仅多孔涂层于1987年改为全周、1988年提供羟基磷灰石涂层选项、1999年增加偏心距选项。
  • 共332例患者(396髋)完成至少25年随访(范围25至37年),手术平均年龄48岁(范围21至70岁),未失败患者平均随访29年(范围25至37年)。

主要发现

  • 共31例股骨翻修(7.8%):感染9例、骨长入失败3例、无菌性松动5例、骨溶解但固定良好8例、假体周围骨折2例、聚乙烯磨损伴大转子撕脱2例、组件断裂1例、对线不良但固定良好1例。
  • 37年时以全因股骨柄翻修为终点的Kaplan-Meier生存率为94.8%(95%CI:±0.9%),以无菌性松动/骨长入失败为终点的生存率为98.7%(95%CI:±0.5)。
  • Harris髋关节评分从术前43显著提高至最近随访76。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have reported excellent results with tapered, titanium, porous plasma-sprayed components in patients undergoing uncemented primary total hip arthroplasty (THA). The purpose of this study was to examine survival and clinical results at a minimum 25-year follow-up. METHODS: We reviewed all patients who underwent primary THA at our center through 1995 with a specific femoral component that was essentially unchanged since its 1984 introduction, except porous coating was continued circumferentially in 1987, a hydroxyapatite-coated option was offered in 1988, and an offset option was added in 1999. There were 332 patients (396 THA) who had a minimum 25-year follow-up (range, 25 to 37). Mean age at surgery was 48 years (range, 21 to 70 years). Mean follow-up in nonfailed patients was 29 years (range, 25 to 37 years). RESULTS: There were 31 femoral revisions (7.8%): 9 infections, 3 failures of ingrowth, 5 aseptic loosening, 8 osteolysis well-fixed, 2 periprosthetic fractures, 2 polyethylene wear with trochanteric avulsion, 1 component breakage, and 1 malalignment well-fixed. Kaplan-Meier survival with the endpoint of all-cause stem revision was 94.8% (95% confidence interval: ±0.9%) at 37 years, and with the endpoint of aseptic loosening/failure of ingrowth was 98.7% (95% confidence interval: ±0.5) at 37 years. Harris hip scores improved significantly from 43 preoperatively to 76 most recently. CONCLUSION: This tapered, titanium, porous plasma spray-coated femoral component continues to demonstrate high long-term survival with a low rate of femoral component revision for any reason or aseptic loosening/failure of ingrowth.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Alexander JS, Lombardi AV, Berend KR, et al. Minimum 25-Year Results of a Tapered Titanium Porous Plasma Spray Coated Femoral Component. J Arthroplasty. 2023. PMID: 36924856. doi:10.1016/j.arth.2023.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。